Technology | June 28, 2006

Test Makes Early Risk Stratification Possible


The Elecsys proBNP assay is the first and only natriuretic peptide test to receive FDA clearance for the risk assessment of cardiac events in people who have stable coronary artery disease β€” nearly 13 million in the U.S.
Available for use on the Roche Elecsys systems and MODULAR ANALYTICS E170 immunoassay analyzers, the test is used as an aid in the diagnosis of individuals suspected of congestive heart failure, and as a marker of risk for patients with acute coronary syndrome (ACS) and congestive heart failure. The immunoassay analyzer has a sample throughput of up to 170 tests per hour and includes tests for thyroid, fertility, anemia, cardiac markers, tumor markers and bone markers, among others.
An early marker of cardiac involvement in these disease processes, proBNP enables physicians to identify at-risk patients, learn more about their cardiac status and determine the best treatment and therapy early on.


Related Content

Technology | Blood Testing

October 9, 2019 β€” Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received ...

Home October 09, 2019
Home
News | Blood Testing

September 18, 2019 β€” Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high ...

Home September 18, 2019
Home
News | Blood Testing

March 19, 2019 β€” Prevencio Inc. announced data confirming the high accuracy of its artificial intelligence (AI)-driven ...

Home March 19, 2019
Home
News | Blood Testing

December 28, 2018 β€”Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche ...

Home December 28, 2018
Home
News | Blood Testing

October 26, 2018 β€” For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians ...

Home October 26, 2018
Home
News | Blood Testing

October 24, 2018 β€” For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes ...

Home October 24, 2018
Home
News | Blood Testing

October 16, 2018 β€” Abbott announced that its High Sensitive Troponin-I blood test has received CE Mark for distribution ...

Home October 16, 2018
Home
News | Blood Testing

September 4, 2018 β€” Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral ...

Home September 04, 2018
Home
News | Blood Testing

August 6, 2018 β€” A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency ...

Home August 06, 2018
Home
News | Blood Testing

March 26, 2018 β€” Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singulex ...

Home March 26, 2018
Home
Subscribe Now